Personalized Treatment Strategies in Glioblastoma: MGMT Promoter Methylation Status

OncoTargets and Therapy - New Zealand
doi 10.2147/ott.s50208
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

MGMT Methylation Status: The Advent of Stratified Therapy in Glioblastoma?

Disease Markers
BiochemistryMedicineClinical BiochemistryMolecular BiologyGenetics
2007English

The Predictive but Not Prognostic Value of MGMT Promoter Methylation Status in Elderly Glioblastoma Patients: A Meta-Analysis

PLoS ONE
Multidisciplinary
2014English

Treatment Results, Including Clinical Prognostic Factors and MGMT Gene Promoter Methylation, in Patients With Glioblastoma Multiforme in Warmia and Mazury Oncology Centre

Wspolczesna Onkologia
OncologyRadiologyNuclear MedicineImaging
2011English

18f-FDG-Pet-Based Radiomics Signature Predicts MGMT Promoter Methylation Status in Primary Diffuse Glioma

Cancer Imaging
Nuclear MedicineRadiologyUltrasound TechnologyOncologyRadiologicalImagingMedicine
2019English

Prognostic Value of MGMT Promoter Methylation in Glioblastoma Patients Treated With Temozolomide-Based Chemoradiation: A Portuguese Multicentre Study

Oncology Reports
MedicineCancer ResearchOncology
2010English

Novel Recursive Partitioning Analysis Classification for Newly Diagnosed Glioblastoma: A Multi-Institutional Study Highlighting the MGMT Promoter Methylation and IDH1 Gene Mutation Status

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2017English

Continuing the Search for MR Imaging Biomarkers for MGMT Promoter Methylation Status: Conventional and Perfusion MRI Revisited

Neuroradiology
Nuclear MedicineRadiologyCardiologyNeurologyCardiovascular MedicineImaging
2011English

Predictive MGMT Status in a Homogeneous Cohort of IDH Wildtype Glioblastoma Patients

Acta neuropathologica communications
Forensic MedicineMolecular NeurosciencePathologyNeurologyCellular
2019English

Prognostic or Predictive Value of MGMT Promoter Methylation in Gliomas Depends on IDH1 Mutation

Neurology
Neurology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy